EGFR and non-small cell lung carcinoma: To assess the adequacy and efficacy of the IdyllaTM system in testing EGFR mutations in cytological specimens of non-small-cell lung cancer (NSCLC), we reviewed the international literature identifying 4 articles describing 471 cases [7,65,66].